A more recent study shed light on the augurin-mediated NF-κB signaling inhibition in a panel of bladder cancer cell lines (J82, BC-5367, UMUC3, BIU-87, and T24) [44]. Here, NFKB1 is linked to urinary bladder carcinoma.